A Study of Infliximab in Patients With Sarcoidosis
NCT00073437
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
139
Enrollment
INDUSTRY
Sponsor class
Conditions
Sarcoidosis
Interventions
DRUG:
Infliximab
Sponsor
Centocor, Inc.